Cytomegalovirus Antibodies IgG, CMV IgG (Serum)
The study is aimed at detecting IgG class antibodies to cytomegalovirus (CMV).
Used for determining past infection and presence of immunity to the virus.
Prescribed when planning pregnancy to assess the risk of infection transmission to the fetus.
Included in TORCH screening (comprehensive examination for infections dangerous to the fetus).
Applied in chronic infectious-inflammatory conditions to assess the patient's immune status.
What the test assesses:
– Presence of IgG antibodies to CMV in serum.
– Fact of past infection and formed immunity.
– Helps the physician determine whether there is protection against reinfection or risk of primary infection.
Biomaterial: Venous blood (serum)
– Submit fasting.
– Avoid alcohol consumption and intense physical exertion for 24 hours before the test.
– Optimal to submit the test in the morning.
Medications:
– As prescribed by a doctor.
– Be sure to inform your doctor about all medications and supplements taken.
Recommended for testing:
– When planning pregnancy or managing pregnancy with high risk of TORCH infections.
– For assessing immune status and preventing complications in chronic or recurring infections.
– With general infectious-inflammatory conditions and when immune response assessment is needed.
– Positive result (IgG detected): indicates past infection and presence of immunity. Primary infection at this time is unlikely.
– Negative result (IgG absent): the body has not encountered the virus or immunity has not formed, there is a risk of primary infection, especially during pregnancy.
Important — IgM testing and CMV PCR are used to assess current or recent infection.
